MARKER THERAPEUTICS INC.
MARKER THERAPEUTICS INC.
Share · US57055L2060 · MRKR · A3D5YK (XNCM)
Overview Financial Indicators
1,58 EUR
18,42 % 0,25 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 22:17

Current Prices from MARKER THERAPEUTICS INC.

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MRKR
USD
06.06.2025 22:17
1,80 USD
1,52 USD
+18,42 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 17,31 % 58,93 % 6,94 % -51,48 % -48,76 % -92,06 %

Company Profile for MARKER THERAPEUTICS INC. Share

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

Company Data

Name MARKER THERAPEUTICS INC.
Company Marker Therapeutics, Inc.
Symbol MRKR
Website https://www.markertherapeutics.com
Primary Exchange XNCM Frankfurt
WKN A3D5YK
ISIN US57055L2060
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Juan F. Vera M.D.
Market Capitalization 12 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 3200 Southwest Freeway, 77027 Houston
IPO Date 2002-07-16

ID Changes

Date From To
19.10.2018 TPIV MRKR

Ticker Symbols

Name Symbol
Frankfurt GX1.F
NASDAQ MRKR

More Shares

Investors who MARKER THERAPEUTICS INC. hold also have the following shares in their portfolio:
ENEL CHILE SA ADR REGS/50
ENEL CHILE SA ADR REGS/50 Depository Receipt
INVESCO S&P MIDCAP 400 EQUAL WEIGHT ETF
INVESCO S&P MIDCAP 400 EQUAL WEIGHT ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025